Skip to main content
. 2021 Apr 15;26(15):2001695. doi: 10.2807/1560-7917.ES.2021.26.15.2001695

Table 3. SARS-CoV-2 infection attack rates (%) by symptoms and age category in schools in a city in northern France, 13 January–19 April 2020 (n = 2,004 participants).

Symptoms Children < 12 years (n = 546) Children 12–17 years (n = 313) Adults (n = 1,145)
Number
of individuals
Proportion with the symptom
(%)
Number infected Proportion with the symptom infected
(%)
p value Number
of individuals
Proportion with the symptom
(%)
Number infected Proportion with the symptom infected
(%)
p value Number
of individuals
Proportion with the symptom
(%)
Number infected Proportion with the symptom infected
(%)
p value
Fever
Yes 121 22.2 13 10.7 0.30 84 26.8 33 39.3 0.03 254 22.2 81 31.9 < 0.001
No 425 77.8 33 7.8 229 73.2 61 26.6 891 77.8 85 9.5
Cough
Yes 124 22.7 8 6.5 0.37 105 32.9 32 30.5 0.90 349 30.5 87 24.9 < 0.001
No 422 77.3 38 9.0 208 66.5 62 29.8 796 69.5 79 9.9
Dyspnoea
Yes 20 3.7 3 15.0 0.28 33 10.5 5 15.1 0.05 157 13.7 49 31.2 < 0.001
No 526 96.3 43 8.2 280 89.5 89 31.8 988 86.3 117 11.8
Ageusia
Yes 4 0.7 0 0 0.99 19 6.1 17 89.5 < 0.001 94 8.2 76 80.9 < 0.001
No 542 99.3 46 8.5 294 93.9 77 26.2 1,051 91.7 90 8.6
Anosmia
Yes 2 0.4 0 0 0.99 20 6.4 16 80.0 < 0.001 85 7.4 76 89.4 < 0.001
No 544 99.6 46 8.5 293 93.6 78 26.6 1,060 92.6 90 8.5
Myalgia
Yes 40 7.3 4 10.0 0.71 55 17.6 19 34.5 0.42 268 23.4 83 31.0 < 0.001
No 506 92.7 42 8.3 258 82.4 75 29.1 877 76.6 83 9.5
Sore throat
Yes 90 16.5 8 8.9 0.86 87 27.8 25 28.7 0.76 261 22.8 53 20.3 0.002
No 456 83.5 38 8.3 226 72.2 69 30.5 884 77.2 113 12.8
Rhinorrhoea
Yes 97 17.8 10 10.3 0.46 114 36.4 41 36.0 0.08 283 24.7 62 21.9 < 0.001
No 449 82.2 36 8.0 199 63.5 53 26.6 862 75.3 104 12.1
Headache
Yes 101 18.5 8 7.9 0.84 91 29.1 31 34.1 0.32 332 29.0 84 25.3 < 0.001
No 445 81.5 38 8.5 222 70.9 63 28.4 813 71.0 82 10.1
Asthenia
Yes 79 14.4 11 13.9 0.06 77 24.6 26 33.8 0.41 350 30.6 95 27.1 < 0.001
No 467 85.5 35 7.5 236 75.4 68 28.8 795 69.4 71 8.9
Chest pain
Yes 0 0 0 0 NA 0 0 0 0 - 7 0.6 0 0 0.61
No 546 100 46 8.4 313 100 94 30.0 1,138 99.4 166 14.6
Nausea
Yes 3 0.5 1 33.3 0.23 3 1.0 2 66.7 0.22 10 0.9 4 40.0 0.04
No 543 99.5 45 8.3 310 99.0 92 29.7 1,135 99.1 162 14.3
Vomiting
Yes 23 4.2 1 4.3 0.71 13 4.2 5 38.5 0.54 18 1.6 2 11.1 0.99
No 523 95.8 45 8.6 300 95.8 89 29.7 1,127 98.4 164 14.6
Abdominal pain
Yes 6 1.1 0 0 0.99 2 0.6 0 0 0.99 12 1.0 4 33.3 0.08
No 540 98.9 46 8.5 311 99.4 94 30.2 1,133 99.0 162 14.3
Diarrhoea
Yes 50 9.2 9 18.0 0.01 37 11.8 17 45.9 0.03 151 13.2 38 25.2 < 0.001
No 496 90.8 37 7.5 276 88.2 77 27.9 994 86.8 128 12.9
Symptom severity
None 274 50.2 20 7.3 0.62 110 35.1 22 20.0 0.01 429 37.5 14 3.3 < 0.001
Minora only 89 16.3 8 9.0 54 17.3 15 27.8 214 18.7 14 6.5
Majorb 183 33.5 18 9.8 149 47.6 57 38.3 502 43.8 138 27.5
Medical consultationc
Yes 99 36.4 8 8.1 0.53 44 21.7 17 38.6 0.62 255 35.6 73 28.6 < 0.001
No 173 63.6 18 10.4 159 78.3 55 34.6 461 64.4 79 17.1
Hospitalisation
Yes 1 0.2 0 0 0.99 4 1.3 2 50.0 0.59 14 1.2 9 64.3 < 0.001
No 545 99.8 46 8.5 309 98.7 92 29.8 1,131 98.8 157 13.9

NA: not applicable.

a Minor symptoms included asthenia, diarrhoea, headache, myalgia, rhinitis, and sore throat.

b Major symptoms included ageusia and anosmia, fever, dry cough and dyspnoea.

c Only among participants who declared symptoms, including children < 12 years (n = 272); children 12–17 years (n = 203); adults (n = 716).